(opens in new tab)
www.itmedia.co.jp
News
Anthropic launches its own “drug discovery activities,” acquires a pediatric biomedicine startup with a single employee, and advances research on treatments for pediatric rare diseases - ITmedia NEWS
Translated title. Original: Anthropic、独自の“創薬活動”に着手 社員1人のバイオ企業を買収、小児難病の治療薬研究を進める - ITmedia NEWS
Anthropic announces in-house drug discovery efforts, acquiring a one-person pediatric biotech, Mithril Medicine. Using Claude to coordinate external labs, data, and early antibody candidates for two pediatric muscular dystrophy targets, they report promising mouse results and rapid screening with CROs, while acknowledging some drafting/quantity errors. If continued success, human trials may begin by late 2028.